EUVIMEDEUVIMED entdecken
Open Access

Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms

Fangda Li iD, Zaofeng Yang iD, Thomas M Savage iD, Rosa L Vincent iD, Kenia de Los Santos-Alexis iD, Alexander Ahn iD, Mathieu Rouanne iD, Dylan L Mariuzza iD, Tal Danino iD, Nicholas Arpaia iD

Science Immunology · 18.10.2024 · 9 (100)

DOI: 10.1126/sciimmunol.adn9879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 18.10.2024. Verfasst von Fangda Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferon-γ (IFN-γ) is a potent cytokine critical for response to immunotherapy, yet conventional methods to systemically deliver this cytokine have been hindered by severe dose-limiting toxicities. Here, we engineered a strain of probiotic bacteria that home to tumors and locally release IFN-γ. A single intratumoral injection of these IFN-γ–producing bacteria was sufficient to drive systemic tumor antigen–specific antitumor immunity, without observable toxicity. Although cancer cells use various resistance mechanisms to evade immune responses, bacteria-derived IFN-γ overcame primary resistance to programmed cell death 1 (PD-1) blockade via activation of cytotoxic Foxp3 − CD4 + and CD8 + T cells. Moreover, by activating natural killer (NK) cells, bacteria-derived IFN-γ also overcame acquired resistance mechanisms to PD-1 blockade, specifically loss-of-function mutations in IFN-γ signaling and antigen presentation pathways. Collectively, these results demonstrate the promise of combining IFN-γ–producing bacteria with PD-1 blockade as a therapeutic strategy for overcoming immunotherapy-resistant, locally advanced, and metastatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsProgrammed Cell Death 1 ReceptorAnimalsFemaleHumansMiceCell Line, TumorImmunotherapyInterferon-gammaMice, Inbred C57BL

Substanzen

Immune Checkpoint InhibitorsInterferon-gammaProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Columbia University, New York, NY, USA.
  • Department of Biomedical Engineering, Columbia University, New York, NY, USA.
  • Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
  • Data Science Institute, Columbia University, New York, NY, USA.

ORCID-Profile: Fangda Li, Zaofeng Yang, Thomas M Savage, Rosa L Vincent, Kenia de Los Santos-Alexis, Alexander Ahn, Mathieu Rouanne, Dylan L Mariuzza, Tal Danino, Nicholas Arpaia

Förderung

  • NCI NIH HHS

Zitieren

APA

Li, F., Yang, Z., Savage, T. M., Vincent, R. L., de Los Santos-Alexis, K., Ahn, A., Rouanne, M., Mariuzza, D. L., Danino, T., & Arpaia, N. (2024). Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms. Science Immunology, 9(100). https://doi.org/10.1126/sciimmunol.adn9879

Vancouver

Li F, Yang Z, Savage TM, Vincent RL, de Los Santos-Alexis K, Ahn A, et al. Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms. Science Immunology. 2024;9(100). doi:10.1126/sciimmunol.adn9879

BibTeX
@article{Li2024,
  author = {Li, Fangda and Yang, Zaofeng and Savage, Thomas M and Vincent, Rosa L and de Los Santos-Alexis, Kenia and Ahn, Alexander and Rouanne, Mathieu and Mariuzza, Dylan L and Danino, Tal and Arpaia, Nicholas},
  title = {Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms},
  journal = {Science Immunology},
  year = {2024},
  volume = {9},
  number = {100},
  doi = {10.1126/sciimmunol.adn9879}
}
Kostenlos starten →